Clean Energy Fuels (CLNE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for May 22, 2025, will be held virtually via live audio webcast.
Supplement provides updated information regarding the Amended and Restated 2024 Performance Incentive Plan.
Voting matters and shareholder proposals
Stockholders are asked to vote on the Amended and Restated 2024 Performance Incentive Plan (Proposal 4).
Board recommends a vote "FOR" the approval of the Amended 2024 Plan.
Executive compensation and say-on-pay
As of March 14, 2025, weighted-average exercise price for all outstanding options is $5.47.
Weighted-average remaining term for all outstanding options is 6.52 years.
Performance-based vesting options have a weighted-average exercise price of $6.77 and remaining term of 6.74 years.
Non-performance-based options have a weighted-average exercise price of $4.99 and remaining term of 6.44 years.
Latest events from Clean Energy Fuels
- Record RNG volumes and project milestones drove higher 2025 revenue but deeper net losses.CLNE
Q4 202524 Feb 2026 - Q2 2024 revenue hit $98M, Adjusted EBITDA up 56%, net loss steady, guidance improved.CLNEQ2 20242 Feb 2026
- Q3 2024 revenue and EBITDA rose, RNG sales set a record, but regulatory risks persist.CLNEQ3 202416 Jan 2026
- RNG leadership, robust financials, and new engine tech drive growth in heavy-duty fleet markets.CLNE2024 Southwest IDEAS Conference12 Jan 2026
- RNG volumes and revenue grew in 2024, but 2025 outlook is cautious due to credit and asset headwinds.CLNEQ4 202423 Dec 2025
- Shareholders will vote on board elections, auditor, executive pay, and a major equity plan increase.CLNEProxy Filing2 Dec 2025
- Key votes include board elections, auditor ratification, and executive pay approval.CLNEProxy Filing2 Dec 2025
- Revenue grew to $102.6M, RNG volumes rose, but higher non-cash charges widened net loss.CLNEQ2 202523 Nov 2025
- Net loss hit $135M on non-cash charges, but cash and Adjusted EBITDA improved.CLNEQ1 202519 Nov 2025